The researchers reported significantly higher mRNA expression for P2X7R, NLRP3, caspase-1, IL-18, and IL-1β in patients with SS who developed MALT-NHL over the follow-up, compared to both SS patients who did not develop lymphoma and controls. This evidence concerns the gene NLRP3 and synovial sarcoma.